Cargando…

Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease

Background: As most clinical trials have been performed in more symptomatic and higher-risk patients, evidence regarding treatment in patients with Global Initiative for Chronic Obstructive Lung Disease (GOLD) group A chronic obstructive pulmonary disease (COPD) is limited. We assessed the distribut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Sun Hye, Kim, Deog Kyeom, Kim, Sang-Heon, Shin, Tae Rim, Jung, Ki-Suck, Yoo, Kwang Ha, Hwang, Ki-Eun, Park, Hye Yun, Jo, Yong Suk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224662/ https://www.ncbi.nlm.nih.gov/pubmed/35743701 http://dx.doi.org/10.3390/jpm12060916

Ejemplares similares

The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease
por: Park, Ji Won, et al.
Publicado: (2023)

The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients
por: Yoon, Jung-Ki, et al.
Publicado: (2020)

Exhaled Nitric Oxide in Patients with Stable Chronic Obstructive Pulmonary Disease: Clinical Implications of the Use of Inhaled Corticosteroids
por: Jo, Yong Suk, et al.
Publicado: (2020)

Association of the Neutrophil-to-Lymphocyte Ratio with Lung Function and Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
por: Lee, Heock, et al.
Publicado: (2016)

Longitudinal change of FEV(1) and inspiratory capacity: clinical implication and relevance to exacerbation risk in patients with COPD
por: Jo, Yong Suk, et al.
Publicado: (2019)

Addition of Montelukast to Low-Dose Inhaled Corticosteroid Leads to Fewer Exacerbations in Older Patients Than Medium-Dose Inhaled Corticosteroid Monotherapy
por: Ye, Young-Min, et al.
Publicado: (2015)

Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts
por: Lee, Se Hee, et al.
Publicado: (2019)

Comparison of Korean COPD Guideline and GOLD Initiative Report in Term of Acute Exacerbation: A Validation Study for Korean COPD Guideline
por: Hwang, Yong Il, et al.
Publicado: (2014)

Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2022)

Air Trapping and the Risk of COPD Exacerbation: Analysis From Prospective KOCOSS Cohort
por: Kim, Youlim, et al.
Publicado: (2022)

Racial Differences in Prevalence and Clinical Characteristics of Asthma–Chronic Obstructive Pulmonary Disease Overlap
por: Jo, Yong Suk, et al.
Publicado: (2021)

Relationship Between Changes in Inhalation Treatment Level and Exacerbation of Chronic Obstructive Pulmonary Disease: Nationwide the Health Insurance and Assessment Service Database
por: Jo, Yong Suk, et al.
Publicado: (2020)

Impact of BMI on exacerbation and medical care expenses in subjects with mild to moderate airflow obstruction
por: Jo, Yong Suk, et al.
Publicado: (2018)

Chronic cough as a novel phenotype of chronic obstructive pulmonary disease
por: Koo, Hyeon-Kyoung, et al.
Publicado: (2018)

What Can We Apply to Manage Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Acute Respiratory Failure?
por: Kim, Deog Kyeom, et al.
Publicado: (2018)

Effect of low protein intake on acute exacerbations in mild to moderate chronic obstructive pulmonary disease: data from the 2007–2012 KNHANES
por: Park, Sojung, et al.
Publicado: (2021)

Radiographic Phenotypes Affect the Risk of Inhaled Corticosteroid-Associated Pneumonia in Patients with COPD
por: Lee, Hyo Jin, et al.
Publicado: (2022)

Association of body mass index and COPD exacerbation among patients with chronic bronchitis
por: Shin, Sun Hye, et al.
Publicado: (2022)

Inhaled Corticosteroids in Asthma and the Risk of Pneumonia
por: Kim, Min-Hye, et al.
Publicado: (2019)

Which GOLD B patients progress to GOLD D with the new classification?
por: Choi, Hye Sook, et al.
Publicado: (2018)

Impact of gender on chronic obstructive pulmonary disease outcomes: a propensity score-matched analysis of a prospective cohort study
por: Cho, Jaeyoung, et al.
Publicado: (2020)

Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease
por: Lee, Jung-Kyu, et al.
Publicado: (2019)

Efficacy and predictors of response to inhaled corticosteroid treatment for chronic cough
por: Hong, Ji Young, et al.
Publicado: (2019)

Cut-off value of FEV(1)/FEV(6) to determine airflow limitation using handheld spirometry in subjects with risk of chronic obstructive pulmonary disease
por: Hwang, Yong Il, et al.
Publicado: (2021)

When is LABA/LAMA Better than LAMA in GOLD Group B or D Patients for Reducing Acute Exacerbations of COPD?
por: Shin, Hong-Joon, et al.
Publicado: (2023)

Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation
por: Jo, Yong Suk, et al.
Publicado: (2017)

Definitions of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Exacerbation: A Modified Delphi Survey
por: Park, Yong Bum, et al.
Publicado: (2023)

Risk of acute exacerbations in chronic obstructive pulmonary disease associated with biomass smoke compared with tobacco smoke
por: Cho, Jaeyoung, et al.
Publicado: (2019)

Development of a daily predictive model for the exacerbation of chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2023)

Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity
por: Lee, Hyun, et al.
Publicado: (2017)

Factors associated with chronic obstructive pulmonary disease exacerbation, based on big data analysis
por: Lee, Jongmin, et al.
Publicado: (2019)

Association between Serum Levels of Interleukin-25/Thymic Stromal Lymphopoietin and the Risk of Exacerbation of Chronic Obstructive Pulmonary Disease
por: Choi, Joon Young, et al.
Publicado: (2023)

Korean Asthma Guideline 2014: Summary of Major Updates to the Korean Asthma Guideline 2014
por: Kim, Deog Kyeom, et al.
Publicado: (2016)

The cutoff point of clinical chronic obstructive pulmonary disease questionnaire for more symptomatic patients
por: Jo, Yong Suk, et al.
Publicado: (2018)

Clinical impacts of the classification by 2017 GOLD guideline comparing previous ones on outcomes of COPD in real-world cohorts
por: Song, Jin Hwa, et al.
Publicado: (2018)

Frequent Outpatient Visits Prevent Exacerbation of Chronic Obstructive Pulmonary Disease
por: Park, Hye Jung, et al.
Publicado: (2020)

Risk of Pneumonia Associated With the Use of Inhaled Corticosteroids in Asthma
por: Kim, Sang-Heon
Publicado: (2019)

Non-adherence to inhaled corticosteroids and the risk of asthma exacerbations in children
por: Vasbinder, Erwin C, et al.
Publicado: (2016)

Validation of the Rome proposal for severity of acute exacerbation of chronic obstructive pulmonary disease
por: Lee, Hyo Jin, et al.
Publicado: (2023)

Active case finding strategy for chronic obstructive pulmonary disease with handheld spirometry
por: Kim, Joo Kyung, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f96co0ei4t6to7opt2o0oh05gr